Precision Medical Group, backed by Berkshire Partners, TPG Growth, awaits first round bids 

Berkshire, which co-led a $275 million investment in Precision in late 2017 alongside TPG Growth, intends to remain invested in the provider of clinical trial and drug commercialization services.

Share this